Surgery Partners (NASDAQ:SGRY) Stock Price Down 7.4%

Surgery Partners, Inc. (NASDAQ:SGRYGet Rating)’s stock price traded down 7.4% during trading on Wednesday . The stock traded as low as $42.87 and last traded at $42.99. 3,862 shares changed hands during trading, a decline of 99% from the average session volume of 604,561 shares. The stock had previously closed at $46.43.

A number of equities analysts recently issued reports on SGRY shares. Zacks Investment Research lowered Surgery Partners from a “hold” rating to a “sell” rating in a report on Tuesday, May 10th. Benchmark increased their price objective on Surgery Partners from $65.00 to $72.00 in a report on Wednesday, May 4th. SVB Leerink increased their price objective on Surgery Partners from $63.00 to $65.00 and gave the stock an “outperform” rating in a report on Wednesday, March 2nd. StockNews.com raised Surgery Partners from a “sell” rating to a “hold” rating in a report on Thursday, May 12th. Finally, Citigroup increased their price objective on Surgery Partners from $61.00 to $64.00 in a report on Wednesday, May 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $60.11.

The stock has a market capitalization of $3.81 billion, a price-to-earnings ratio of -80.58, a P/E/G ratio of 12.52 and a beta of 2.76. The company has a quick ratio of 1.61, a current ratio of 1.73 and a debt-to-equity ratio of 1.50. The business has a 50-day simple moving average of $52.56 and a two-hundred day simple moving average of $49.89.

Surgery Partners (NASDAQ:SGRYGet Rating) last released its earnings results on Tuesday, May 3rd. The company reported ($0.09) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02. Surgery Partners had a negative return on equity of 0.46% and a negative net margin of 1.63%. During the same period in the prior year, the business earned ($0.40) earnings per share. On average, analysts forecast that Surgery Partners, Inc. will post 0.1 EPS for the current year.

In other news, insider George Goodwin sold 25,525 shares of the stock in a transaction on Thursday, April 21st. The stock was sold at an average price of $62.58, for a total transaction of $1,597,354.50. Following the completion of the sale, the insider now owns 57,990 shares in the company, valued at approximately $3,629,014.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Wayne S. Deveydt sold 966 shares of the business’s stock in a transaction on Friday, March 11th. The shares were sold at an average price of $55.11, for a total transaction of $53,236.26. The disclosure for this sale can be found here. Insiders have sold a total of 116,220 shares of company stock valued at $6,300,372 in the last quarter. Insiders own 3.30% of the company’s stock.

A number of large investors have recently made changes to their positions in the business. Signaturefd LLC acquired a new position in shares of Surgery Partners in the fourth quarter worth $63,000. PNC Financial Services Group Inc. increased its stake in shares of Surgery Partners by 34.7% in the first quarter. PNC Financial Services Group Inc. now owns 1,195 shares of the company’s stock worth $66,000 after acquiring an additional 308 shares during the last quarter. Nisa Investment Advisors LLC increased its stake in shares of Surgery Partners by 444.4% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,960 shares of the company’s stock worth $84,000 after acquiring an additional 1,600 shares during the last quarter. Allspring Global Investments Holdings LLC acquired a new position in shares of Surgery Partners in the fourth quarter worth $92,000. Finally, Balyasny Asset Management LLC acquired a new position in shares of Surgery Partners in the third quarter worth $203,000.

About Surgery Partners (NASDAQ:SGRY)

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Featured Stories

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.